These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19841143)

  • 1. Assessment of the in vitro kinetic activity of caspofungin against Candida glabrata.
    Nagappan V; Boikov D; Vazquez JA
    Antimicrob Agents Chemother; 2010 Jan; 54(1):522-5. PubMed ID: 19841143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
    Mario DA; Denardi LB; Bandeira LA; Antunes MS; Santurio JM; Severo LC; Alves SH
    Mem Inst Oswaldo Cruz; 2012 May; 107(3):433-6. PubMed ID: 22510843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains.
    Denardi LB; Keller JT; Oliveira V; Mario DAN; Santurio JM; Alves SH
    Mycopathologia; 2017 Oct; 182(9-10):819-828. PubMed ID: 28493006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic activities of three triazoles with caspofungin against Candida glabrata isolates determined by time-kill, Etest, and disk diffusion methods.
    Kiraz N; Dag I; Yamac M; Kiremitci A; Kasifoglu N; Oz Y
    Antimicrob Agents Chemother; 2010 May; 54(5):2244-7. PubMed ID: 20194697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
    Chen TC; Chen YH; Chen YC; Lu PL
    Kaohsiung J Med Sci; 2012 Jun; 28(6):306-15. PubMed ID: 22632885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.
    Ko KS; Lee JY; Song JH; Peck KR
    J Korean Med Sci; 2010 Dec; 25(12):1722-6. PubMed ID: 21165285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.
    Ruan SY; Chu CC; Hsueh PR
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2919-22. PubMed ID: 18458136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata.
    Oliveira ER; Fothergill AW; Kirkpatrick WR; Coco BJ; Patterson TF; Redding SW
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3544-5. PubMed ID: 16048980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fungicidal activity of the human peptide hepcidin 20 alone or in combination with other antifungals against Candida glabrata isolates.
    Tavanti A; Maisetta G; Del Gaudio G; Petruzzelli R; Sanguinetti M; Batoni G; Senesi S
    Peptides; 2011 Dec; 32(12):2484-7. PubMed ID: 22015266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticandidal effects of voriconazole and caspofungin, singly and in combination, against Candida glabrata, extracellularly and intracellularly in granulocyte-macrophage colony stimulating factor (GM-CSF)-activated human monocytes.
    Baltch AL; Bopp LH; Smith RP; Ritz WJ; Michelsen PB
    J Antimicrob Chemother; 2008 Dec; 62(6):1285-90. PubMed ID: 18772160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal activity of caspofungin in combination with amphotericin B against Candida glabrata: comparison of disk diffusion, Etest, and time-kill methods.
    Kiraz N; Dag I; Yamac M; Kiremitci A; Kasifoglu N; Akgun Y
    Antimicrob Agents Chemother; 2009 Feb; 53(2):788-90. PubMed ID: 19029317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes.
    Posteraro B; Sanguinetti M; Fiori B; La Sorda M; Spanu T; Sanglard D; Fadda G
    J Antimicrob Chemother; 2006 Aug; 58(2):458-61. PubMed ID: 16757500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro Synergistic Activity of Caspofungin Plus Polymyxin B Against Fluconazole-Resistant Candida glabrata.
    Adams EK; Ashcraft DS; Pankey GA
    Am J Med Sci; 2016 Mar; 351(3):265-70. PubMed ID: 26992255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
    González GM; Elizondo M; Ayala J
    J Clin Microbiol; 2008 Sep; 46(9):2902-5. PubMed ID: 18632907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species,
    Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E
    Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.
    Di Bonaventura G; Spedicato I; Picciani C; D'Antonio D; Piccolomini R
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4453-6. PubMed ID: 15504881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis.
    Chaturvedi V; Ramani R; Andes D; Diekema DJ; Pfaller MA; Ghannoum MA; Knapp C; Lockhart SR; Ostrosky-Zeichner L; Walsh TJ; Marchillo K; Messer S; Welshenbaugh AR; Bastulli C; Iqbal N; Paetznick VL; Rodriguez J; Sein T
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1543-8. PubMed ID: 21282457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex.
    Cordeiro RA; Macedo RB; Teixeira CEC; Marques FJF; Bandeira TJPG; Moreira JLB; Brilhante RSN; Rocha MFG; Sidrim JJC
    J Med Microbiol; 2014 Jul; 63(Pt 7):936-944. PubMed ID: 24722799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biguanides enhance antifungal activity against Candida glabrata.
    Xu S; Feliu M; Lord AK; Lukason DP; Negoro PE; Khan NS; Dagher Z; Feldman MB; Reedy JL; Steiger SN; Tam JM; Soukas AA; Sykes DB; Mansour MK
    Virulence; 2018; 9(1):1150-1162. PubMed ID: 29962263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of Candida species to four antifungal agents assessed by the reference broth microdilution method.
    Eksi F; Gayyurhan ED; Balci I
    ScientificWorldJournal; 2013; 2013():236903. PubMed ID: 24250260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.